Emonyvin Adverse Event Reporting

Ciencia Therapeutics strives to create safe, effective therapies for everyone. Occasionally some patients do experience an adverse Event from one of our drugs. If this happens, please tell your healthcare provider immediately and then report it to us. This will allow us to continue to track the safety of our therapies, and further our research to provide the safest, most effective therapies available.

You will be able to upload relevant images in a variety of standard formats (*.jpg, *.gif, *.png, *.pdf) so please have those available as you begin to complete the information.

Adverse Event Reporting

EMONYVIN is a prescription medicine used to treat people with relapsing forms of Acquired Metastructurel Pediculosis and Collins Syndrome in adults.

Important Information

Patients should always consult their healthcare provider for medical advice about adverse events. If you are participating in a clinical trial, please report the adverse event to your coordinating study site.
Additionally, please be aware of the alternative reporting methods. In the United States you may visit the U.S. Food & Drug Administration (FDA) directly.

Visit FDA Website